The researchers asked this question: “What is the association of combat exposure with suicide attempts among active-duty US service members who were deployed in support of the wars in Iraq and Afghanistan?”
The researchers conducted genome-wide association studies of PTSD in military veterans to explore the genetic association with the common comorbidities of depression and anxiety.
The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.
In a cohort study of older veterans with combat or military related PTSD, the brief ISI was significantly correlated with results from the original yet longer ISI.
Another unintended consequence of the COVID-19 pandemic is posttraumatic stress disorder, which Shulkin has experience with in his capacity working with veterans.
The number of veterans being diagnosed with attention-deficit/hyperactivity disorder is increasing.
Gulf War illness poses a high disease burden on veterans almost three decades after the conflict.
The findings of the study challenge concerns that exposure therapy may worsen symptoms in patients with PTSD, particularly when comorbid SUD is present.
The number and timing of follow-up psychotherapy visits may be inadequate to deliver evidence-based psychotherapy.
